Mike Petegorsky: Mindbloom’s At-home Ketamine Therapy, MDMA vs FDA Issues, & Taking Ketamine – 252

Mindbloom is a mental health and wellbeing company helping people achieve personal and clinical breakthroughs with at-home, clinician-prescribed psychedelic therapies. Mike Petegorsky is the Chief Strategy Officer at Mindbloom. Michael was previously a commercial and IP case litigator for Fortune 50 companies at NYC firms Akin Gump and Ropes & Gray. Michael was named One to Watch by Best Lawyers in America and is a charter member of TechGC, an invitation-only community for General Counsels of venture backed high growth startups. He received his J.D. from Fordham University School of Law and B.A. from the University of Pennsylvania. Other psychedelics episodes to check outBrom Rector - psychedelic investor: https://youtu.be/XX5QlHbDHBsDr. Jacob Aday - psychedelic researcher: https://youtu.be/8JUS92TvGroDr. Joseph Zamaria - board-certified psychologist : https://youtu.be/JjpZ2Eqw2XUSam Believe - ayahuasca psychedelic retreat: https://youtu.be/1JOmSVheiBwDr. Parker Kelley - psychoimmunology, biomedical sciences, psychedelics: https://youtu.be/1M-tN4cnM3Y PODCAST INFO:The Learning With Lowell show is a series for the everyday mammal. In this show we’ll learn about leadership, science, and people building their change into the world. The goal is to dig deeply into people who most of us wouldn’t normally ever get to hear. The Host of the show – Lowell Thompson- is a lifelong autodidact, serial problem solver, and founder of startups. LINKSSpotify: https://open.spotify.com/show/66eFLHQclKe5p3bMXsCTRHRSS: https://www.learningwithlowell.com/feed/podcast/Youtube: https://www.youtube.com/channel/UCzri06unR-lMXbl6sqWP_-QYoutube clips: https://www.youtube.com/channel/UC-B5x371AzTGgK-_q3U_KfAWebsite: https://www.learningwithlowell.com Mike Petegorsky linkshttps://www.mindbloom.com/https://www.linkedin.com/in/michael-petegorsky-41059614/ Timestamps00:00 Start / introducing Mike Petegorsky and mindbloom leading business offering at-home ketamine therapy01:32 Mike Petegorsky’s journey from IP fortune 50 lawyer to Mindbloom04:30 USA SSRI capital of the world05:30 Mental health professionals need better resources to help06:30 Ketamine vs SSRIs vs just therapy09:30 Withdrawal and ketamine10:24 why Mike Petegorsky used ketamine / Mindbloom’s ketamine protocol13:00 Mike Petegorsky’s first ketamine experience17:40 Psychedelics and ketamine therapy / Mike Petegorsky’s core belief19:10 Meditation giving more anxiety vs after ketamine therapy20:25 sam harris meditation app21:30 Lowell’s experience in the hospital23:30 “Bad” experiences with Ketamine and provider fails / what ketamine feels like27:30 Mindbloom therapy explained28:30 Mike Petegorsky’s IP background applied Mindbloom / Patents in psychedelics33:30 Mindbloom developing IP38:15 Mindbloom ketamine therapy cost40:50 Mindbloom telemedicine benefits / anxiety, PTSD, convenience42:20 VFW partnership to help veterans with anxiety, depression, and PTSD45:00 Mike Petegorsky path to Congress / telemedicine / psychedelics50:41 Mike Petegorsky’s process to get Congress to take his meetings53:30 Mindbloom Not outsourcing core competency / how to high level network57:20 Psychedelics vs other therapies to help people59:24 Cold Emails / Cold out reach / People want to help01:02:30 Respecting people’s time01:03:45 Mindbloom & 15 Commitments of Conscious Leadership01:06:18 MDMA’s FDA federal approval drama explained01:08:50 FDA committee wrong on all counts / Effectiveness and safety01:16:22 Placebo vs control group01:16:50 Why Mike Petegorsky believes the FDA is going to approve anyway01:18:30 People need MDMA now / safety explained01:26:40 Bias in the FDA committee against psychedelics01:30:40 Potential for bias and undue influence01:32:43 Why FDA will over rule FDA committee01:33:35 Mindbloom future psychedelic therapies / Dr. Joe Zamaria question01:36:18 Mindbloom focus vs doing too much at once01:38:00 MDMA truck / buses and law response01:40:20 “If you will it,